NYSE:ATNM | Free Cash Flow | Actinium Pharmaceuticals, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2010-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$5.87M$2,000.00-$5.87M
2025-12-31-$5.29M
2025-03-31-$7.57M
2024-12-31-$5.75M$0.00-$5.75M
2024-03-31-$7.37M$11,000.00-$7.39M
2023-12-31-$7.49M$0.00-$7.49M
2023-03-31-$15.08M$76,000.00-$15.15M
2022-12-31-$7.78M$16,000.00-$7.79M
2022-03-31-$5.78M$7,000.00-$5.79M
2021-12-31-$5.05M$0.00-$5.05M
2021-03-31-$5.64M$4,000.00-$5.65M
2020-12-31-$6.26M$245,000.00-$6.5M
2020-03-31-$5.85M
2019-12-31-$5.01M$5,000.00-$5.02M
2019-03-31-$5.49M$51,000.00-$5.54M
2018-12-31-$4.29M$10,570.00-$4.3M
2018-03-31-$5.46M$6,991.00-$5.47M
2017-12-31-$3.17M$1,259.00-$3.17M
2017-03-31-$5.37M$8,313.00-$5.38M
2016-12-31-$4.24M$17,231.00-$4.26M
2016-03-31-$4.76M$27,590.00-$4.78M
2015-12-31-$3.96M$20,843.00-$3.99M
2015-03-31-$5.81M
2014-12-31-$5.05M$814.00-$5.05M
2014-03-31-$2.49M$1,699.00-$2.49M
2013-12-31-$1.34M$8,562.00-$1.35M
2013-03-31-$2.31M$1,112.00-$2.31M
2012-12-31-$1.42M$547.00-$1.42M
2012-03-31-$947,927.00$1,157.00-$949,084.00
2011-12-31-$522,547.00
2010-12-31-$5,075.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$24.58M$104,000.00-$24.68M
2024-12-31-$33.07M$11,000.00-$33.08M
2023-12-31-$47.34M$153,000.00-$47.49M
2022-12-31$8.64M$366,000.00$8.28M
2021-12-31-$20.87M$133,000.00-$21M
2020-12-31-$21.62M$253,000.00-$21.87M
2019-12-31-$21.46M$64,000.00-$21.53M
2018-12-31-$20.57M$96,092.00-$20.67M
2017-12-31-$21.55M$24,739.00-$21.58M
2016-12-31-$20.79M$59,960.00-$20.85M
2015-12-31-$18.54M$47,788.00-$18.59M
2014-12-31-$14.35M$151,688.00-$14.5M
2013-12-31-$6.29M$16,592.00-$6.31M
2012-12-31-$5.21M$2,359.00-$5.22M
2011-12-31-$517,592.00
2010-12-31$7,835.00